CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling - PubMed (original) (raw)
. 2001 Jan 18;409(6818):349-54.
doi: 10.1038/35053086.
T Sasaki, W Matsumoto, A Opavsky, M Cheng, G Welstead, E Griffiths, C Krawczyk, C D Richardson, K Aitken, N Iscove, G Koretzky, P Johnson, P Liu, D M Rothstein, J M Penninger
Affiliations
- PMID: 11201744
- DOI: 10.1038/35053086
CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling
J Irie-Sasaki et al. Nature. 2001.
Abstract
The regulation of tyrosine phosphorylation and associated signalling through antigen, growth-factor and cytokine receptors is mediated by the reciprocal activities of protein tyrosine kinases and protein tyrosine phosphatases (PTPases). The transmembrane PTPase CD45 is a key regulator of antigen receptor signalling in T and B cells. Src-family kinases have been identified as primary molecular targets for CD45 (ref. 4). However, CD45 is highly expressed in all haematopoietic lineages at all stages of development, indicating that CD45 could regulate other cell types and might act on additional substrates. Here we show that CD45 suppresses JAK (Janus kinase) kinases and negatively regulates cytokine receptor signalling. Targeted disruption of the cd45 gene leads to enhanced cytokine and interferon-receptor-mediated activation of JAKs and STAT (signal transducer and activators of transcription) proteins. In vitro, CD45 directly dephosphorylates and binds to JAKs. Functionally, CD45 negatively regulates interleukin-3-mediated cellular proliferation, erythropoietin-dependent haematopoieisis and antiviral responses in vitro and in vivo. Our data identify an unexpected and novel function for CD45 as a haematopoietic JAK phosphatase that negatively regulates cytokine receptor signalling.
Similar articles
- CD45 recruits adapter protein DOK-1 and negatively regulates JAK-STAT signaling in hematopoietic cells.
Wu L, Bijian K, Shen SH. Wu L, et al. Mol Immunol. 2009 Jul;46(11-12):2167-77. doi: 10.1016/j.molimm.2009.04.032. Epub 2009 May 28. Mol Immunol. 2009. PMID: 19481264 - Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
Okutani Y, Kitanaka A, Tanaka T, Kamano H, Ohnishi H, Kubota Y, Ishida T, Takahara J. Okutani Y, et al. Oncogene. 2001 Oct 4;20(45):6643-50. doi: 10.1038/sj.onc.1204807. Oncogene. 2001. PMID: 11641791 - The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus.
Heim MH. Heim MH. J Recept Signal Transduct Res. 1999 Jan-Jul;19(1-4):75-120. doi: 10.3109/10799899909036638. J Recept Signal Transduct Res. 1999. PMID: 10071751 Review. - CD45: new jobs for an old acquaintance.
Penninger JM, Irie-Sasaki J, Sasaki T, Oliveira-dos-Santos AJ. Penninger JM, et al. Nat Immunol. 2001 May;2(5):389-96. doi: 10.1038/87687. Nat Immunol. 2001. PMID: 11323691 Review.
Cited by
- Causal relationship, shared genes between rheumatoid arthritis and pulp and periapical disease: evidence from GWAS and transcriptome data.
Wu H, Wang L, Qiu C. Wu H, et al. Front Immunol. 2024 Sep 13;15:1440753. doi: 10.3389/fimmu.2024.1440753. eCollection 2024. Front Immunol. 2024. PMID: 39346909 Free PMC article. - CD45 threads the needle of cytokine cancer immunotherapy.
Wellhausen N, Gill S. Wellhausen N, et al. Nat Immunol. 2024 Oct;25(10):1775-1777. doi: 10.1038/s41590-024-01956-0. Nat Immunol. 2024. PMID: 39251801 No abstract available. - Combination of dual JAK/HDAC inhibitor with regorafenib synergistically reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancer.
Bajpai P, Agarwal S, Afaq F, Al Diffalha S, Chandrashekar DS, Kim HG, Shelton A, Miller CR, Singh SK, Singh R, Varambally S, Nagaraju GP, Manne A, Paluri R, Khushman M, Manne U. Bajpai P, et al. J Exp Clin Cancer Res. 2024 Jul 11;43(1):192. doi: 10.1186/s13046-024-03106-8. J Exp Clin Cancer Res. 2024. PMID: 38992681 Free PMC article. - Integrative network analysis of transcriptomics data reveals potential prognostic biomarkers for colorectal cancer.
Mahajan M, Sarkar A, Mondal S. Mahajan M, et al. Cancer Med. 2024 Jun;13(11):e7391. doi: 10.1002/cam4.7391. Cancer Med. 2024. PMID: 38872418 Free PMC article. - Reduction of phosphorylated signal transducer and activator of transcription-5 expression in feline mammary carcinoma.
Owaki K, Murakami M, Kato K, Hirata A, Sakai H. Owaki K, et al. J Vet Med Sci. 2024 Jul 2;86(7):816-823. doi: 10.1292/jvms.23-0470. Epub 2024 May 21. J Vet Med Sci. 2024. PMID: 38777776 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous